Imperial College London Diabetes Centre
14
0
0
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
The Role of Gut Hormones and Hepcidin in Type 2 Diabetes Mellitus
Role: lead
Abu Dhabi Diabetes and Obesity Study -2 Bariatric
Role: lead
Abu Dhabi Diabetes and Obesity Study
Role: lead
Application of UCPCR as a Testing Tool for Identification of MODY Patients in the UAE
Role: lead
Genetic Causes of Gestational Diabetes in the Emirati Population
Role: lead
Genetic Causes of Hypercholesterolaemia in the Emirati Population
Role: lead
Ramadan Flash Glucose Monitoring Study
Role: lead
Genetic and Epigenetic Risk of T2D in the UAE
Role: lead
Effect of Camel Milk on Insulin and Incretin Response
Role: lead
Delineation of Novel Monogenic Disorders in the United Arab Emirates Population
Role: lead
Cognitive Function and Body Mass Index in Children and Adolescents
Role: lead
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
Role: collaborator
Ramadan and Energy Expenditure Study
Role: lead
Abu Dhabi Sleep Apnea (ADSA) Study
Role: lead
All 14 trials loaded